TREATMENT RESULTS FOR SQUAMOUS CELL CARCINOMA OF THE LATERAL OROPHARYNX WALL
|
Accession number;04A0146728
|
| Title;TREATMENT RESULTS FOR SQUAMOUS CELL CARCINOMA OF THE LATERAL OROPHARYNX WALL |
| Author;
ONITSUKA TETSURO
(National Cancer Center Hospital East, JPN)
EBIHARA SATOSHI
(National Cancer Center Hospital East, JPN)
OYAMA WAICHIRO
(National Cancer Center Hospital East, JPN)
SAIKAWA MASAHISA
(National Cancer Center Hospital East, JPN)
HANEDA TATSUMASA
(National Cancer Center Hospital East, JPN)
KISHIMOTO SEIJI
(Tokyo Medical and Dental Univ., JPN)
KAWASHIMA MITSUHIKO
(National Cancer Center Hospital East, JPN)
OGINO TAKASHI
(National Cancer Center Hospital East, JPN)
IKEDA HIROSHI
(National Cancer Center Hospital East, JPN)
|
Journal Title;Head and Neck Cancer
|
Journal Code:Y0503A
|
ISSN:0911-4335
|
|
VOL.28;NO.1;PAGE.12-17(2002)
|
| Figure&Table&Reference;FIG.6, TBL.4, REF.14 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;The treatment results of 83 cases of squamous cell carcinoma in the lateral wall of the oropharynx, between 1982 and 1995, were reviewed. The 5-year cause-specific survival rate, and the 5-year local control rate, were 59% and 69%, respectively. In T1 and T2 cases, 5-year rates of the ultimate local control, including patients succesfully treated with salvage operation after local recurrence, were 86% by radiation therapy, and 80% by surgery. T3 cases with ulcer and endophytic broad growth to adjacent area were uncured even by radical surgery. Therefore, such T3 cases should be treated with concomitant chemoradiotherapy. The 5-year absolute survival rate was 49%, similar to the data before 1982. It is considered that the low survival rate was influenced by second primary cancers. Patients with oropharyngeal cancer should be followed carefully as to a second primary cancer, and given therapy that does not reduce the patients' quality of life. (author abst.) |
|
|
|
Related Articles;
|
|
